Equity Profile

SNN

Smith & Nephew plc

Health CareHealth Care Equipment$13.0B

Feb20Thu

Pre-Earnings Brief

UpcomingQ4-2019Pre-Market9:00 AM EST

Company Snapshot

Smith & Nephew plc (SNN) operates in the health care sector, focusing on medical equipment and advanced wound management. As a player in the health care equipment industry, its performance is influenced by trends in healthcare spending and innovations in medical technology.

Key Metrics to Watch

Revenue Growth

Revenue growth is crucial for understanding how well the company is expanding its market presence and meeting customer needs.

N/A

Earnings Per Share (EPS)

EPS is a key indicator of profitability and is closely watched by investors to gauge financial health.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

SNN Q4-2019 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

25%

Avg EPS Surprise

+19.92%

Avg Stock Reaction

+0.05%

Last Quarter Recap

In the last quarter, Smith & Nephew reported an EPS of $0.92, showing a positive trend compared to previous quarters. The stock reacted positively, gaining 1.23% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, Wall Street is cautiously optimistic about Smith & Nephew's upcoming earnings report, especially given its recent performance.

Bull Case

If the company reports strong revenue growth and maintains or improves its EPS, it could signal robust demand for its products and lead to a stock price increase.

Bear Case

Conversely, if the earnings report reveals disappointing sales figures or a decrease in market share, it could raise concerns about the company's competitive position and lead to a stock decline.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the revenue growth rate compared to last year?

This figure will be critical in assessing the company's ability to capture market demand and compete effectively.

How is Smith & Nephew performing in the wound management segment?

Given its focus on this area, insights into market share and product performance will be key indicators of future growth.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for Smith & Nephew to outperform in the wound management sector, given recent innovations.

Supporting Evidence

The company has a strong history of product launches that have driven sales growth.

Options pricing suggests higher volatility, indicating that traders expect significant movement, which may not align with consensus expectations.

Key Risk

If the revenue growth exceeds expectations, it could challenge the current cautious outlook.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will hinge on the company's ability to demonstrate growth in a competitive landscape.

Bull Confirmed If

Revenue growth of 10% or more year-over-year would confirm strong demand and market positioning.

Bear Confirmed If

A revenue decline or stagnation could indicate challenges in maintaining market share.

Pre-Earnings Positioning

Options Market

Implied Move

±5%

Historical Avg

±2.4%

Pricing rich

The options market is pricing in a potential move of 5%, suggesting that traders expect some volatility around the earnings announcement.

Options are pricing ±5.0% while SNN has averaged ±2.4% over the last 8 prints — setup is pricing rich.

Detail

30d HV

25.2%

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

History suggests that a strong earnings beat could lead to a stock increase of around 2.89%, confirming positive market sentiment.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further guidance.

Miss

A disappointing earnings report could result in a decline of approximately 1.11%, reflecting investor concerns.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches in the wound management segment.
2Details on market share changes in key product categories.
3Management's outlook on future revenue growth.
4Insights into cost management and operational efficiency.
5Any commentary on competitive pressures in the health care equipment market.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Feb17

SCIReported

Service Corporation International

RecapView

Feb17

FLSReported

Company Snapshot

Key Metrics to Watch

Revenue Growth

Revenue growth is crucial for understanding how well the company is expanding its market presence and meeting customer needs.

N/A

Earnings Per Share (EPS)

EPS is a key indicator of profitability and is closely watched by investors to gauge financial health.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

SNN Q4-2019 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

25%

Avg EPS Surprise

+19.92%

Avg Stock Reaction

+0.05%

Last Quarter Recap

In the last quarter, Smith & Nephew reported an EPS of $0.92, showing a positive trend compared to previous quarters. The stock reacted positively, gaining 1.23% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, Wall Street is cautiously optimistic about Smith & Nephew's upcoming earnings report, especially given its recent performance.

Bull Case

If the company reports strong revenue growth and maintains or improves its EPS, it could signal robust demand for its products and lead to a stock price increase.

Bear Case

Conversely, if the earnings report reveals disappointing sales figures or a decrease in market share, it could raise concerns about the company's competitive position and lead to a stock decline.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the revenue growth rate compared to last year?

This figure will be critical in assessing the company's ability to capture market demand and compete effectively.

How is Smith & Nephew performing in the wound management segment?

Given its focus on this area, insights into market share and product performance will be key indicators of future growth.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for Smith & Nephew to outperform in the wound management sector, given recent innovations.

Supporting Evidence

The company has a strong history of product launches that have driven sales growth.

Options pricing suggests higher volatility, indicating that traders expect significant movement, which may not align with consensus expectations.

Key Risk

If the revenue growth exceeds expectations, it could challenge the current cautious outlook.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will hinge on the company's ability to demonstrate growth in a competitive landscape.

Bull Confirmed If

Revenue growth of 10% or more year-over-year would confirm strong demand and market positioning.

Bear Confirmed If

A revenue decline or stagnation could indicate challenges in maintaining market share.

Pre-Earnings Positioning

Options Market

Implied Move

±5%

Historical Avg

±2.4%

Pricing rich

The options market is pricing in a potential move of 5%, suggesting that traders expect some volatility around the earnings announcement.

Options are pricing ±5.0% while SNN has averaged ±2.4% over the last 8 prints — setup is pricing rich.

Detail

30d HV

25.2%

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

History suggests that a strong earnings beat could lead to a stock increase of around 2.89%, confirming positive market sentiment.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further guidance.

Miss

A disappointing earnings report could result in a decline of approximately 1.11%, reflecting investor concerns.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches in the wound management segment.
2Details on market share changes in key product categories.
3Management's outlook on future revenue growth.
4Insights into cost management and operational efficiency.
5Any commentary on competitive pressures in the health care equipment market.